The appointment follows�NewcelX's recently announced successful FDAType B Pre-IND meeting for NCEL-101, providing a clear regulatory pathway toward clinical trials ... .
Camillo Ricordi, to Scientific Advisory Board... Ricordi to support advancement of NewcelX's Type 1 Diabetes program and ... Ricordi has played a central role in advancing cell-based approaches for type 1 diabetes worldwide ... Camillo Ricordi.